Horizon Therapeutics Public Ltd Co

D. E. Shaw & Co., Inc.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

4,718,246

Value ($000)

545,854

Weight

0.9%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	545,854	0.9%	4,718,246	9/30/2023
2023 Q2	8/14/2023	378,733	0.6%	3,682,380	6/30/2023
2023 Q1	5/15/2023	242,873	0.4%	2,225,338	3/31/2023
2022 Q4	2/14/2023	9,114	0.0%	80,090	12/31/2022
2022 Q3	11/14/2022	25,633	0.0%	414,178	9/30/2022
2022 Q2	8/15/2022	1,899	0.0%	23,810	6/30/2022
2022 Q1	5/16/2022	28,488	0.0%	270,774	3/31/2022
2021 Q4	2/14/2022	15,721	0.0%	145,893	12/31/2021
2021 Q3	11/15/2021	27,959	0.0%	255,237	9/30/2021
2021 Q2	8/16/2021	39,769	0.0%	424,701	6/30/2021
2021 Q1	5/17/2021	148,870	0.2%	1,617,448	3/31/2021
2020 Q4	2/16/2021	168,519	0.2%	2,303,746	12/31/2020
2020 Q3	11/16/2020	236,117	0.3%	3,039,613	9/30/2020
2020 Q2	8/14/2020	165,207	0.2%	2,972,432	6/30/2020
2020 Q1	5/15/2020	127,891	0.2%	4,317,753	3/31/2020
2019 Q4	2/14/2020	185,856	0.3%	5,134,157	12/31/2019